With rapid development in sequencing technology, researchers can better assess the effect of the gut microbiome on human health. Human beings have a symbiotic relationship with the microbiota since birth. The environment, proximity to other humans and animals, diet, genetics, and time changes can all affect the microbial composition of our skin, mouth, and intestines. Compared with other previously unknown organs, the microbiota has extensive metabolic functions and carries 1,000 times more genes than the human genome.
Metabolomics is an important omics technology based on high-throughput analysis technology (chromatography-mass spectrometry, NMR) and bioinformatics. It has progressed considerably in the past ten years, and its use has been broadened in various fields of life science and medical research. In addition to the advantages of conventional non-target exploratory analysis, metabolomics can also detect specific metabolites related to intestinal bacteria, clearly reflecting the functional change of intestinal flora under specific conditions. Combined with the sequencing analysis technology of intestinal bacteria, a key strategy for studying the relationship between intestinal flora and disease, intestinal flora and drug metabolism/pharmacodynamics, is formed.
The gut microbiota is increasingly recognized as important drug targets. Specific microorganisms can inactivate or activate specific exogenous substances, thereby changing the effects of different therapeutic drugs. Metabolomics and metabolite analysis can be widely used to identify clinical disease biomarkers. For example, quantitative analysis of triglyceride, glucose, and cholesterol levels in the blood can be used to determine the risk of heart disease. The initial microbiome studies attempted to identify bacterial taxa related to diseases, physiological conditions, drug use, or dietary intake.
Metabolomics analysis can also help us study the effects of rare and genetically mutated bacterial groups on metabolic functions. If a rare bacterial group has important metabolic functions, it may have a great impact on the metabolome of the entire community. The core functions of intestinal flora can be influenced by the available substrates (for example, exogenous substances), even if the microbial species composition and abundance remain unchanged.
Different microbial communities metabolize exogenous substances and dietary components differently, and their effects on host tissues also vary. The host impacts the composition of the gut microbiota, gene expression, and material metabolism through diet or ingestion of exogenous substances. The gut microbiota metabolizes diet and exogenous substances into metabolites. These metabolites enter through the blood and affect the host peripherally. For example, drugs can be metabolized by the flora and become less effective, or they can be converted into non-target and potentially toxic derivatives. Changes in these metabolites alter the metabolomics characteristics of the intestines, thereby having variable effects on the host. At the same time, the new host phenotype can, in turn, have a feedback effect on the microbial community.
Creative Proteomics is a preeminent corporation specializing in multi-omics. We are equipped with state-of-the-art techniques to provide one-stop gut microbiota metabolomics services for your research.
As a part of it, significant quantities of cheese are being consumed as an ingredient in a wide variety of food products such as cheese-based dishes/snacks in the home, food service, and prepared consumer foods.
Cheese, be it blue cheese, cheddar cheese, pecorino cheese, muenster cheese, and gouda cheese, act as an additional benefit to most of the diets because of its low fat and sodium content.
Cheese is a rich source of nutrients including protein such as casein, whey & calcium and vitamins namely A, B2 (riboflavin) and B12, phosphorous and zinc.
Additionally, the intake of cheese supports weight loss, prevents heart diseases, and osteoporosis.
Furthermore, cheese manufacturers focus engaged in developing different cheese formulations in fresh, unripened, cooked, pressed, and aged varieties, which is helpful to raise their cheese ingredients market share.
As a consequence, the cheese ingredients market size stood at $89.9 billion in 2018 and is projected to grow at a CAGR of 3% during the forecast period 2019-2025, according to the global cheese ingredients market report.
The global Gut Microbiome Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the gut microbiome market include Viome, Carbiotix, Ixcela, Inc., Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics, AnimalBiome, and Assembly Biosciences.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Gut Microbiome Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/gut-microbiome-market/download-sampleMarket DynamicsThe high prevalence of homeostatic physiological disorders and inflammatory bowel diseases among the global population provides the main impetus for this market's growth.
Rising investments from government and private organizations in the research and development of novel therapeutics, health-conscious communities, and increased healthcare expenditure are the major factors for the steady growth of this market.
Lack of expertise and resources are some of the restraints on the market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
